Abstract
I (D.A.S.) am honored to be able to make this contribution. Although other presenters have dwelled on Tom Merigan's many contributions to both AIDS studies and antiviral chemotherapy generally, I can emphasize another role for him, that of helping to bring interferon (IFN) to the fore of our consciousness [1]. I have the pleasant, unique role of being the only contributor not now identified with virology, and I will address the discipline to which I transitioned after fellowship with Tom-a place where, it turns out, IFN has an important host role [2]. Charles Prober, of the Department of Pediatrics at Stanford, recently made me aware that I have been, with my colleagues, publishing on IFN in 5 different decades now.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
